Europe • Frankfurt Stock Exchange • FRA:ABL • US0028241000
Overall ABL gets a fundamental rating of 6 out of 10. We evaluated ABL against 68 industry peers in the Health Care Equipment & Supplies industry. ABL scores excellent on profitability, but there are some minor concerns on its financial health. ABL is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.18 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.53 | ||
| Fwd PE | 19.33 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.87 | ||
| EV/EBITDA | 17.23 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.38% |
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 21.53 and the Price/Book (PB) ratio is 3.78.
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 28.93%.